Poor survival for veterans with pathologic stage I non–small-cell lung cancer - 08/11/12
Corresponding author. Tel.: +1-615-322-0064; fax: +1-615-343-9194Abstract |
Background |
Pathologic stage (pStage) IA and IB non–small-cell lung cancer (NSCLC) has a median survival time of 119 and 81 months, respectively. We describe the outcomes of veterans with pStage I NSCLC.
Methods |
A retrospective review of 78 patients with pStage I NSCLC who underwent cancer resection was performed at the Tennessee Valley Veterans Affairs Hospital between 2005 and 2010. All-cause 30-day, 90-day, and overall mortality were determined. Survival was assessed with the Kaplan–Meier and Cox proportional hazards methods.
Results |
There were 55 (71%) pStage IA and 23 (29%) IB patients. Thirty- and 90-day mortality was 3.8% (3 of 78) and 6.4% (5 of 78), respectively. Median survival was 59 and 28 months for pStage 1A and 1B, respectively. Postoperative events were associated with impaired survival on multivariable analysis (hazard ratio, 1.26, P = .03).
Conclusions |
Veterans with pStage I NSCLC at our institution have poorer survival than the general population. More research is needed to determine the etiology of this disparity.
Le texte complet de cet article est disponible en PDF.Keywords : Veteran, Lung cancer, Non–small-cell lung cancer (NSCLC), Survival
Plan
Vol 204 - N° 5
P. 637-642 - novembre 2012 Retour au numéro
Article précédent
- Analyzer-based phase-contrast x-ray imaging of carotid plaque microstructure
- Alyssa A. Appel, Cheng-Ying Chou, Howard P. Greisler, Jeffery C. Larson, Sunil Vasireddi, Zhong Zhong, Mark A. Anastasio, Eric M. Brey
- Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility
- Faisal G. Bakaeen, Biswajit Kar, Danny Chu, Lorraine D. Cornwell, Alvin Blaustein, Glenn N. Levine, David Paniagua, Hani Jneid, Corey Jensen, Prasad V. Atluri, Carlos F. Bechara, Panos Kougias, Chris Pawlak, Biykem Bozkurt, Thomas A. Burdon, Blase A. Carabello
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?